ApprovalTrail

Approval · Notice of Compliance 277 · 2004

NU-VERAP SR: Notice of Compliance 277

Issued March 23, 2004

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
277
Date
March 23, 2004
Company
Nu-Pharm IncVaughan, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Admin
Reason
New manufacturer and product name
Therapeutic class
Antihypertensive agent
Canadian reference product
ISOPTIN SR (Knoll Pharma Inc.)

Products in this notice

BrandDINStatus today
NU-VERAP SR02249812Cancelled Post Market

Medicinal ingredients